Back to Search
Start Over
Author Correction: Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
- Source :
-
Nature medicine [Nat Med] 2024 Jan; Vol. 30 (1), pp. 304. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1546-170X
- Volume :
- 30
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Nature medicine
- Accession number :
- 37845513
- Full Text :
- https://doi.org/10.1038/s41591-023-02639-3